Mohan Singh, PhD
Scientist at USC Michelson Center for Convergent Bioscience
Complex nature of cancer makes it difficult for clinicians to choose right treatment option for cancer patients. Precision medicine is the recent approach to treat patients based on genetic variability and the pattern of protein expression on cancer cells. It’s very important to know what types of cells are surrounding cancer cells and how cancer cells communicate with its neighboring cells. The new method called Imaging Mass Cytometry, enables researchers and clinician to detect multiple proteins on cancer and its surrounding cells. With the help of this technique clinician can recommend targeted therapy for the better outcome of cancer patients.
Dr. Singh earned his PhD in Biochemistry from Panjab University in Chandigarh, India. He went on to conduct postdoctoral research in cancer-related cell signaling pathways and cell metabolism at the University of Quebec, Canada and Children’s Hospital Los Angeles.